JPS50108264A - - Google Patents

Info

Publication number
JPS50108264A
JPS50108264A JP49016062A JP1606274A JPS50108264A JP S50108264 A JPS50108264 A JP S50108264A JP 49016062 A JP49016062 A JP 49016062A JP 1606274 A JP1606274 A JP 1606274A JP S50108264 A JPS50108264 A JP S50108264A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49016062A
Other versions
JPS5849550B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP49016062A priority Critical patent/JPS5849550B2/ja
Publication of JPS50108264A publication Critical patent/JPS50108264A/ja
Publication of JPS5849550B2 publication Critical patent/JPS5849550B2/ja
Expired legal-status Critical Current

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP49016062A 1974-02-07 1974-02-07 シンキナアニリンユウドウタイ ノ セイホウ Expired JPS5849550B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP49016062A JPS5849550B2 (ja) 1974-02-07 1974-02-07 シンキナアニリンユウドウタイ ノ セイホウ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49016062A JPS5849550B2 (ja) 1974-02-07 1974-02-07 シンキナアニリンユウドウタイ ノ セイホウ

Publications (2)

Publication Number Publication Date
JPS50108264A true JPS50108264A (ja) 1975-08-26
JPS5849550B2 JPS5849550B2 (ja) 1983-11-05

Family

ID=11906077

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49016062A Expired JPS5849550B2 (ja) 1974-02-07 1974-02-07 シンキナアニリンユウドウタイ ノ セイホウ

Country Status (1)

Country Link
JP (1) JPS5849550B2 (ja)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152379A (ja) * 1983-02-12 1984-08-31 レコルダチ　エス　エ−　ケミカル　アンド　フアマシユテイカル　カンパニ− Ｎ―ピペラジニルアルカノイルアニリド及びその製造法
EP0628555A1 (de) * 1993-06-08 1994-12-14 Bayer Ag Substituierte(2-Oxo-1-benzimidazolinyl)-piperidine, Verfahren zu ihrer Herstellung und Verwendung als anti-retrovirale Mittel
WO2000078716A1 (fr) * 1999-06-24 2000-12-28 Toray Industries, Inc. ANTAGONISTES DU RECEPTEUR ADRENERGIQUE-α¿1B?
WO2001046200A1 (en) * 1999-12-22 2001-06-28 Astrazeneca Ab Novel piperidine and piperazine derivatives
JP2006511500A (ja) * 2002-10-30 2006-04-06 メルク　エンド　カムパニー　インコーポレーテッド γ−アミノアミド系のケモカイン受容体活性調節剤
DE102005038141A1 (de) * 2005-08-12 2007-02-15 Grünenthal GmbH Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate
CN108290889A (zh) * 2015-09-14 2018-07-17 内盖夫国家生物技术研究所 新的哌嗪和哌啶衍生物、它们的合成及其在抑制vdac寡聚化、细胞凋亡和线粒体功能障碍中的用途
US10946013B2 (en) 2015-09-14 2021-03-16 The National Institute for Biotechnology in the Negev Ltd. Methods for treating central nervous system disorders using vdac inhibitors
US11472777B2 (en) 2015-09-14 2022-10-18 The National Institute for Biotechnology in the Negev Ltd. Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59230441A (ja) * 1983-06-08 1984-12-25 Mitsubishi Electric Corp 回転電機の界磁装置

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290317A (en) * 1960-03-07 1966-12-06 Sterling Drug Inc 1-(nu-aryl-nu-alkanoylaminoalkyl)-4-aryl-4-piperidinols and their esters
US3350403A (en) * 1964-04-07 1967-10-31 Aldrich Chem Co Inc Nu-phenyl amides of 4-phenyl-4-hydroxypiperidino alkyl acids
US3455935A (en) * 1967-06-12 1969-07-15 Miles Lab 4-hydroxy-4-phenylpiperidines
US3539580A (en) * 1967-06-26 1970-11-10 Janssen Pharm 4-aryl-4-aminoalkoxy-piperidines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290317A (en) * 1960-03-07 1966-12-06 Sterling Drug Inc 1-(nu-aryl-nu-alkanoylaminoalkyl)-4-aryl-4-piperidinols and their esters
US3350403A (en) * 1964-04-07 1967-10-31 Aldrich Chem Co Inc Nu-phenyl amides of 4-phenyl-4-hydroxypiperidino alkyl acids
US3455935A (en) * 1967-06-12 1969-07-15 Miles Lab 4-hydroxy-4-phenylpiperidines
US3539580A (en) * 1967-06-26 1970-11-10 Janssen Pharm 4-aryl-4-aminoalkoxy-piperidines

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0434549B2 (ja) * 1983-02-12 1992-06-08 Rekorudachi Sa
JPS59152379A (ja) * 1983-02-12 1984-08-31 レコルダチ　エス　エ−　ケミカル　アンド　フアマシユテイカル　カンパニ− Ｎ―ピペラジニルアルカノイルアニリド及びその製造法
EP0628555A1 (de) * 1993-06-08 1994-12-14 Bayer Ag Substituierte(2-Oxo-1-benzimidazolinyl)-piperidine, Verfahren zu ihrer Herstellung und Verwendung als anti-retrovirale Mittel
US6642228B1 (en) 1999-06-24 2003-11-04 Toray Industries, Inc. α1b-adrenergic receptor antagonists
WO2000078716A1 (fr) * 1999-06-24 2000-12-28 Toray Industries, Inc. ANTAGONISTES DU RECEPTEUR ADRENERGIQUE-α¿1B?
KR100733548B1 (ko) * 1999-12-22 2007-06-28 아스트라제네카 아베 신규 피페리딘 및 피페라진 유도체
WO2001046200A1 (en) * 1999-12-22 2001-06-28 Astrazeneca Ab Novel piperidine and piperazine derivatives
CN1330657C (zh) * 1999-12-22 2007-08-08 阿斯特拉曾尼卡有限公司 哌啶和哌嗪衍生物
JP2006511500A (ja) * 2002-10-30 2006-04-06 メルク　エンド　カムパニー　インコーポレーテッド γ−アミノアミド系のケモカイン受容体活性調節剤
DE102005038141A1 (de) * 2005-08-12 2007-02-15 Grünenthal GmbH Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate
WO2007019987A1 (de) * 2005-08-12 2007-02-22 Grünenthal GmbH Substituierte 8-(3-aminopropyl)-1 -phenyl-1, 3, 8-triaza-spiro[4,5]decan-4-on-derivate zur schmerztherapie
CN108290889A (zh) * 2015-09-14 2018-07-17 内盖夫国家生物技术研究所 新的哌嗪和哌啶衍生物、它们的合成及其在抑制vdac寡聚化、细胞凋亡和线粒体功能障碍中的用途
US10946013B2 (en) 2015-09-14 2021-03-16 The National Institute for Biotechnology in the Negev Ltd. Methods for treating central nervous system disorders using vdac inhibitors
CN108290889B (zh) * 2015-09-14 2021-08-10 内盖夫国家生物技术研究所 新的哌嗪和哌啶衍生物、它们的合成及其在抑制vdac寡聚化、细胞凋亡和线粒体功能障碍中的用途
US11472777B2 (en) 2015-09-14 2022-10-18 The National Institute for Biotechnology in the Negev Ltd. Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction

Also Published As

Publication number Publication date
JPS5849550B2 (ja) 1983-11-05

Similar Documents

Publication Publication Date Title
FR2278045B1 (ja)
FR2266046B1 (ja)
JPS50108264A (ja)
JPS50102928A (ja)
JPS50132064A (ja)
FR2292244B1 (ja)
JPS50126904A (ja)
JPS50101220A (ja)
FR2261270B3 (ja)
JPS50114511A (ja)
JPS50125615U (ja)
JPS50129806A (ja)
CH573571A5 (ja)
BG22566A1 (ja)
CH572375A5 (ja)
CH571727A5 (ja)
CH570190A5 (ja)
CH570173A5 (ja)
CH574819A5 (ja)
CH569288A5 (ja)
CH567385A5 (ja)
CH566532A5 (ja)
CH565470A5 (ja)
CH562601A5 (ja)
CH41675A4 (ja)